Ashmitha Sundarrajan

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity

Xian-Yang Li, Achim K. Moesta, Christos Xiao et al. · Cancer Discovery · 2019 · 256 citations · Full text

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan et al. · Immunity · 2020 · 169 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Activating Receptor Cd226 +9

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Marianne Weulersse, Assia Asrir, Andrea Pichler et al. · Immunity · 2020 · 135 citations · Full text

Eomes-dependent Loss, Cancer Immunosurveillance, T-regulatory Cell +8

Correction of ATM mutations in iPS cells from two ataxia-telangiectasia patients restores DNA damage and oxidative stress responses

Dmitry A. Ovchinnikov, Sarah Withey, Hannah C. Leeson et al. · Human Molecular Genetics · 2020 · 17 citations